Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Siegfried Kasper. (2023) Cheers and a thank-you note from the founding chief-editor. International Journal of Psychiatry in Clinical Practice 27:4, pages 319-322.
Read now
Read now
Rhys Ponton, Garion Gear, Parsa Hadiyounzadeh, Fyrooz Iqram, Anes Kim, Sophanna Out, Wey Ern Thoo, Jane L. Sheridan & David Newcombe. (2023) What Is the Quality of Web-Based Advice for the General Public on Benzodiazepine Misuse and Use Disorder? A Systematic Evaluation of Websites. Journal of Consumer Health on the Internet 27:1, pages 35-52.
Read now
Read now
Valérie Aubut, Vincent Wagner, Marie-Marthe Cousineau & Karine Bertrand. (2021) Problematic Substance Use, Help-Seeking, and Service Utilization Trajectories among Seniors: An Exploratory Qualitative Study. Journal of Psychoactive Drugs 53:1, pages 18-26.
Read now
Read now
Bernardo Dell’Osso, Umberto Albert, Anna Rita Atti, Claudia Carmassi, Giuseppe Carrà, Fiammetta Cosci, Valeria Del Vecchio, Marco Di Nicola, Silvia Ferrari, Arianna Goracci, Felice Iasevoli, Mario Luciano, Giovanni Martinotti, Maria Giulia Nanni, Alessandra Nivoli, Federica Pinna, Nicola Poloni, Maurizio Pompili, Gaia Sampogna, Ilaria Tarricone, Sarah Tosato, Umberto Volpe & Andrea Fiorillo. (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment 11, pages 1885-1909.
Read now
Read now
Sophie Billioti de Gage, Antoine Pariente & Bernard Bégaud. (2015) Is there really a link between benzodiazepine use and the risk of dementia?. Expert Opinion on Drug Safety 14:5, pages 733-747.
Read now
Read now
Nick Heather, Jennifer Paton & Heather Ashton. (2011) Predictors of response to brief intervention in general practice against long-term benzodiazepine use. Addiction Research & Theory 19:6, pages 519-527.
Read now
Read now
Articles from other publishers (109)
Cheng Ho Phua, Kasrin Saisahas, Asamee Soleh, Kiattisak Promsuwan, Jenjira Saichanapan & Warakorn Limbut. (2023) Electrode modified with reduced graphene oxide decorated with gold nanoparticles co-induced by laser for electrochemical alprazolam sensor. Microchemical Journal 195, pages 109380.
Crossref
Crossref
Filip Koniuszewski, Florian D. Vogel, Irena Dajić, Thomas Seidel, Markus Kunze, Matthäus Willeit & Margot Ernst. (2023) Navigating the complex landscape of benzodiazepine- and Z-drug diversity: insights from comprehensive FDA adverse event reporting system analysis and beyond. Frontiers in Psychiatry 14.
Crossref
Crossref
Lisa Colman, Katrijn Delaruelle, Piet Bracke & Melissa Ceuterick. (2023) Trends in the use of benzodiazepine receptor agonists among working-age adults in Belgium from 2004 to 2018. Frontiers in Public Health 11.
Crossref
Crossref
Catherine Pétein, Anne Spinewine, Marie-Laure Laroche, Anne Niquille & Séverine Henrard. (2023) Adaptation and validation of the revised Patients’ Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists. Research in Social and Administrative Pharmacy.
Crossref
Crossref
Marco Kramer, Bianca Ueberberg, Barbara Emons, Julia Göbel-Erkan, Georg Juckel & Ida Sibylle Haussleiter. (2023) Prescription of Sedative Hypnotics in Psychiatric and Somatic Inpatients. GeroPsych.
Crossref
Crossref
Mayra V. Paschoarelli, Mathias S. Kavai, Lucas F. de Lima & William R. de Araujo. (2023) Laser-scribing fabrication of a disposable electrochemical device for forensic detection of crime facilitating drugs in beverage samples. Talanta 255, pages 124214.
Crossref
Crossref
Denong Liu, Qingyu Zhang, Zhijia Zhao, Mengjia Chen, Yanbin Hou, Guanjun Wang, Haowei Shen, Huaqiang Zhu, Yunxin Ji, Liemin Ruan & Zhongze Lou. (2023) Benzodiazepine-Receptor Agonist Utilization in Outpatients with Anxiety Disorder: A Retrospective Study Based on Electronic Healthcare Data from a Large General Tertiary Hospital. Healthcare 11:4, pages 554.
Crossref
Crossref
Michelle S Keller, Johan Carrascoza-Bolanos, Kathleen Breda, Linda Y Kim, Korey A Kennelty, Donna W Leang, Logan T Murry, Teryl K Nuckols, Jeffrey L Schnipper & Joshua M Pevnick. (2023) Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study. BMJ Open 13:2, pages e066234.
Crossref
Crossref
Elif Engin. (2023) GABAA receptor subtypes and benzodiazepine use, misuse, and abuse. Frontiers in Psychiatry 13.
Crossref
Crossref
Deeksha & Ritesh Singh. (2022) Aza‐oxyallyl Cations and Their Applications in (3+m) Cycloaddition Reactions. European Journal of Organic Chemistry 2022:47.
Crossref
Crossref
Emadoddin Amin Sadrabadi, Fatemeh Khosravi, Ali Benvidi, Amin Shiralizadeh Dezfuli, Pouria Khashayar, Patricia Khashayar & Mostafa Azimzadeh. (2022) Alprazolam Detection Using an Electrochemical Nanobiosensor Based on AuNUs/Fe-Ni@rGO Nanocomposite. Biosensors 12:11, pages 945.
Crossref
Crossref
Lisa-Marie Brunner, Franziska Maurer, Kevin Weber, Johannes Weigl, Vladimir M. Milenkovic, Rainer Rupprecht, Caroline Nothdurfter & Andreas Mühlberger. (2022) Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment. Psychopharmacology 239:7, pages 2233-2244.
Crossref
Crossref
Naosuke Hoshina, Erin M. Johnson-Venkatesh, Veronica R. Rally, Jaanvi Sant, Miyuki Hoshina, Mariel P. Seiglie & Hisashi Umemori. (2022) ASD/OCD-Linked Protocadherin-10 Regulates Synapse, But Not Axon, Development in the Amygdala and Contributes to Fear- and Anxiety-Related Behaviors. The Journal of Neuroscience 42:21, pages 4250-4266.
Crossref
Crossref
Simona Zaami, Silvia Graziano, Roberta Tittarelli, Renata Beck & Enrico Marinelli. (2022) BDZs, Designer BDZs and Z-drugs: Pharmacology and Misuse Insights. Current Pharmaceutical Design 28:15, pages 1221-1229.
Crossref
Crossref
Tahreem Ghazal Siddiqui, Maria Torheim Bjelkarøy, Socheat Cheng, Espen Saxhaug Kristoffersen, Ramune Grambaite & Christofer Lundqvist. (2022) The effect of cognitive function and central nervous system depressant use on mortality—A prospective observational study of previously hospitalised older patients. PLOS ONE 17:3, pages e0263024.
Crossref
Crossref
Korrina A. Duffy & C. Neill Epperson. (2021) Evaluating the evidence for sex differences: a scoping review of human neuroimaging in psychopharmacology research. Neuropsychopharmacology 47:2, pages 430-443.
Crossref
Crossref
Byungjick Min, Yejin Ahn, Hyeok-Jun Cho, Woong-Kwon Kwak, Hyung Joo Suh & Kyungae Jo. (2021) GABAA Receptor-Mediated Sleep-Promoting Effect of Saaz–Saphir Hops Mixture Containing Xanthohumol and Humulone. Molecules 26:23, pages 7108.
Crossref
Crossref
Ke-Ting Pan, I-Hsun Li, Hui-Han Kao, Yi-Hsien Chen, Pei-Xun Zhong & Li-Ting Kao. (2021) Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Miryam Sánchez Díaz, María Luisa Martín-Calvo & Ramona Mateos-Campos. (2021) Trends in the Use of Anxiolytics in Castile and Leon, Spain, between 2015–2020: Evaluating the Impact of COVID-19. International Journal of Environmental Research and Public Health 18:11, pages 5944.
Crossref
Crossref
Cathal A. Cadogan, Colin P. Bradley & Kathleen Bennett. (2021) Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study. European Journal of Clinical Pharmacology 77:6, pages 903-912.
Crossref
Crossref
Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Juan Alberto Ospina-Cano, María José Londoño-Serna & Jorge Enrique Machado-Alba. (2021) Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia. Frontiers in Pharmacology 12.
Crossref
Crossref
Mikhail V. Voronin, Yulia V. Vakhitova, Inna P. Tsypysheva, Dmitry O. Tsypyshev, Inna V. Rybina, Rustam D. Kurbanov, Elena V. Abramova & Sergei B. Seredenin. (2021) Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole. International Journal of Molecular Sciences 22:11, pages 5455.
Crossref
Crossref
Waree Boonmee, Kritsada Samoson, Janjira Yodrak, Adul Thiagchanya, Apichai Phonchai & Warakorn Limbut. (2021) Adsorptive Cathodic Stripping Voltammetry for Quantification of Alprazolam. Molecules 26:10, pages 2958.
Crossref
Crossref
Anja Fog Rasmussen, Sarah Sonne Poulsen, Lykke Ida Kaas Oldenburg & Charlotte Vermehren. (2021) The Barriers and Facilitators of Different Stakeholders When Deprescribing Benzodiazepine Receptor Agonists in Older Patients—A Systematic Review. Metabolites 11:4, pages 254.
Crossref
Crossref
Tista Ghosh, Kirk Bol, Maria Butler, Barbara Gabella, Andrea Kingcade, Gabriel Kaplan & Lindsey Myers. (2020) Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015–2017. BMC Public Health 20:1.
Crossref
Crossref
Ching-En Lin, Meei-Shyuan Lee, Sen-Yeong Kao, Chi-Hsiang Chung, Li-Fen Chen, Po-Han Chou, Jia-Fu Lee & Wu-Chien Chien. (2020) Association between concurrent antidepressant and hypnotic treatment and the risk of dementia: A nationwide cohort study. Journal of Affective Disorders 277, pages 549-558.
Crossref
Crossref
Marta Estrela, Maria Teresa Herdeiro, Pedro Lopes Ferreira & Fátima Roque. (2020) The Use of Antidepressants, Anxiolytics, Sedatives and Hypnotics in Europe: Focusing on Mental Health Care in Portugal and Prescribing in Older Patients. International Journal of Environmental Research and Public Health 17:22, pages 8612.
Crossref
Crossref
Elayne D. Ansara. (2020) Management of treatment-resistant generalized anxiety disorder. Mental Health Clinician 10:6, pages 326-334.
Crossref
Crossref
Tien‐Yu Chen, John W. Winkelman, Wei‐Chung Mao, Nian‐Sheng Tzeng, Terry B.J. Kuo, Cheryl C.H. Yang, Hui‐Ju Tsai & Chi‐Shin Wu. (2020) Real‐world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism. Journal of Thrombosis and Haemostasis 18:11, pages 2878-2888.
Crossref
Crossref
Reza Jahani, Seyed Reza Abtahi, Manijeh Nematpour, Hossein Fasihi Dastjerdi, Mohsen Chamanara, Zahra Hami & Babak Paknejad. (2020) Design, synthesis, and pharmacological evaluation of novel 1,2,4-triazol-3-amine derivatives as potential agonists of GABAA subtype receptors with anticonvulsant and hypnotic effects. Bioorganic Chemistry 104, pages 104212.
Crossref
Crossref
Laura C. Maclagan, Colleen J. Maxwell, Daniel A. Harris, Michael A. Campitelli, Christina Diong, Kate L. Lapane, David B. Hogan, Paula Rochon, Nathan Herrmann & Susan E. Bronskill. (2020) Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada. Drugs & Aging 37:11, pages 817-827.
Crossref
Crossref
Hélène Jacqmin-Gadda, Florian Guillet, Clément Mathieu, Catherine Helmer, Antoine Pariente & Pierre Joly. (2020) Impact of benzodiazepine consumption reduction on future burden of dementia. Scientific Reports 10:1.
Crossref
Crossref
Tom Lynch, Cristín Ryan, Carmel M. Hughes, Justin Presseau, Zachary M. Allen, Colin P. Bradley & Cathal A. Cadogan. (2020) Brief interventions targeting long‐term benzodiazepine and Z‐drug use in primary care: a systematic review and meta‐analysis. Addiction 115:9, pages 1618-1639.
Crossref
Crossref
Yeon-Hee Baek, Hye-Jun Kim, Ji-Hwan Bae, Hyesung Lee, In-Sun Oh, Woo Jung Kim & Ju-Young Shin. (2020) Benzodiazepine-Related Cognitive Impairment or Dementia: A Signal Detection Study Using a Case/Non-Case Approach. Psychiatry Investigation 17:6, pages 587-595.
Crossref
Crossref
Babette Bais, Trine Munk-Olsen, Veerle Bergink & Xiaoqin Liu. (2020) Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: A population-based study. Psychiatry Research 288, pages 112993.
Crossref
Crossref
Margot Ernst, Luca L Silva & Florian D Vogel. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
10
.
A. Akila, P. Sakthivel & S. Ponnuswamy. (2020) Synthesis, Characterization, Stereochemistry and Antimicrobial
Evaluation of N-Acyltetrahydrobenzodiazepin-2-ones. Asian Journal of Chemistry 32:5, pages 1007-1014.
Crossref
Crossref
Babette Bais, Nina M. Molenaar, Hilmar H. Bijma, Witte J.G. Hoogendijk, Cornelis L. Mulder, Annemarie I. Luik, Mijke P. Lambregtse-van den Berg & Astrid M. Kamperman. (2020) Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis. Journal of Affective Disorders 269, pages 18-27.
Crossref
Crossref
Amina Antonacci, Viviana Scognamiglio, Vincenzo Mazzaracchio, Veronica Caratelli, Luca Fiore, Danila Moscone & Fabiana Arduini. (2020) Paper-Based Electrochemical Devices for the Pharmaceutical Field: State of the Art and Perspectives. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Blanca Angelica Vega Alanis, Maria Teresa Iorio, Luca L. Silva, Konstantina Bampali, Margot Ernst, Michael Schnürch & Marko D. Mihovilovic. (2020) Allosteric GABAA Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility. Molecules 25:4, pages 999.
Crossref
Crossref
Yeon-Hee Baek, Hyesung Lee, Woo Jung Kim, Jee-Eun Chung, Nicole Pratt, Lisa Kalisch Ellett & Ju-Young Shin. (2020) Uncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study. Journal of the American Medical Directors Association 21:2, pages 201-211.e2.
Crossref
Crossref
Giulia Rivasi, Rose Anne Kenny, Andrea Ungar & Roman Romero-Ortuno. (2020) Effects of benzodiazepines on orthostatic blood pressure in older people. European Journal of Internal Medicine 72, pages 73-78.
Crossref
Crossref
Aline Luiza Marcondes Lopes Oliveira, Mariana Martins Gonzaga do Nascimento, Érico Castro-Costa, Josélia Oliveira Araújo Firmo, Maria Fernanda Lima-Costa & Antônio Ignácio de Loyola Filho. (2020) Aumento da utilização de benzodiazepínicos entre idosos mais velhos: Projeto Bambuí. Revista Brasileira de Epidemiologia 23.
Crossref
Crossref
L Marron, R Segurado, R A Kenny & T McNicholas. (2020) The association between benzodiazepine use and falls, and the impact of sleep quality on this association: data from the TILDA study. QJM: An International Journal of Medicine 113:1, pages 31-36.
Crossref
Crossref
Muhammad Faisal. 2020. Green Sustainable Process for Chemical and Environmental Engineering and Science. Green Sustainable Process for Chemical and Environmental Engineering and Science
113
139
.
Craig Jamieson & Keith LivingstoneCraig Jamieson & Keith Livingstone. 2020. The Nitrile Imine 1,3-Dipole. The Nitrile Imine 1,3-Dipole
37
97
.
Guillaume Airagnes, Cédric Lemogne, Adeline Renuy, Marcel Goldberg, Nicolas Hoertel, Yves Roquelaure, Frédéric Limosin & Marie Zins. (2019) Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort. BMC Public Health 19:1.
Crossref
Crossref
Marija Delaš Aždajić, Robert Likić, Stjepan Aždajić, Mirna Šitum, Ivana Lovrić & Danijela Štimac Grbić. (2019) Outpatient benzodiazepine utilization in Croatia: drug use or misuse. International Journal of Clinical Pharmacy 41:6, pages 1526-1535.
Crossref
Crossref
Honeychurch. (2019) Review of Electroanalytical-Based Approaches for the Determination of Benzodiazepines. Biosensors 9:4, pages 130.
Crossref
Crossref
Guillaume Airagnes, Cédric Lemogne, Sofiane Kab, Nicolas Hoertel, Marcel Goldberg, Morten Wahrendorf, Johannes Siegrist, Yves Roquelaure, Frédéric Limosin & Marie Zins. (2019) Effort–reward imbalance and long-term benzodiazepine use: longitudinal findings from the CONSTANCES cohort. Journal of Epidemiology and Community Health 73:11, pages 993-1001.
Crossref
Crossref
Fatema-Tun-Naher Sake, Keith Wong, Delwyn J. Bartlett & Bandana Saini. (2019) Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs. Research in Social and Administrative Pharmacy 15:11, pages 1317-1325.
Crossref
Crossref
Marco Faccini, Stefano Tamburin, Rebecca Casari, Laura Morbioli & Fabio Lugoboni. (2019) High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde. Internal and Emergency Medicine 14:8, pages 1271-1278.
Crossref
Crossref
S.M. Ahmad & J.M.F. Nogueira. (2019) High throughput bar adsorptive microextraction: A novel cost-effective tool for monitoring benzodiazepines in large number of biological samples. Talanta 199, pages 195-202.
Crossref
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2695.
Crossref
Crossref
Fatema-Tun-Naher Sake, Keith Wong, Delwyn J. Bartlett & Bandana Saini. (2019) Benzodiazepine usage and patient preference for alternative therapies: A descriptive study. Health Science Reports 2:5, pages e116.
Crossref
Crossref
Andrea Bielli, Pilar Bacci, Gabriela Bruno, Nancy Calisto & Santiago Navarro. (2019) ANSIEDAD Y VIDA COTIDIANA COMO BLANCOS FARMACOLÓGICOS EN URUGUAY 2013-2015. Psicologia & Sociedade 31.
Crossref
Crossref
Claudia Fegadolli, Niurka Maria Dupotey Varela & Elisaldo Luis de Araújo Carlini. (2019) Uso e abuso de benzodiazepínicos na atenção primária à saúde: práticas profissionais no Brasil e em Cuba. Cadernos de Saúde Pública 35:6.
Crossref
Crossref
V. De Carlo, B. Grancini, M. Vismara, C. Arici, G. Cirnigliaro, A.C. Altamura & B. Dell'Osso. (2019) Clinical characteristics associated with benzodiazepines’ use in mood, anxiety and psychotic spectrum disorders. European Neuropsychopharmacology 29, pages S89-S90.
Crossref
Crossref
Rachel Podell, Vered Kaufman-Shriqui, Yael Wolff Sagy, Orly Manor & Arie Ben-Yehuda. (2018) The quality of primary care provided to the elderly in Israel. Israel Journal of Health Policy Research 7:1.
Crossref
Crossref
Parker Magin, Amanda Tapley, Adrian J Dunlop, Andrew Davey, Mieke van Driel, Elizabeth Holliday, Simon Morgan, Kim Henderson, Jean Ball, Nigel Catzikiris, Katie Mulquiney, Neil Spike, Rohan Kerr & Simon Holliday. (2018) Changes in Australian Early-Career General Practitioners’ Benzodiazepine Prescribing: a Longitudinal Analysis. Journal of General Internal Medicine 33:10, pages 1676-1684.
Crossref
Crossref
Marie-Michèle Tanguay Bernard, Mireille Luc, Jean-Daniel Carrier, Louise Fournier, Arnaud Duhoux, Elodie Côté, Olivier Lessard, Catherine Gibeault, Christian Bocti & Pasquale Roberge. (2018) Patterns of benzodiazepines use in primary care adults with anxiety disorders. Heliyon 4:7, pages e00688.
Crossref
Crossref
Cathal A. Cadogan, Cristín Ryan, Caitriona Cahir, Colin P. Bradley & Kathleen Bennett. (2018) Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. British Journal of Clinical Pharmacology 84:6, pages 1354-1363.
Crossref
Crossref
Brendan J. Ng, David G. Le Couteur & Sarah N. Hilmer. (2018) Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients. Drugs & Aging 35:6, pages 493-521.
Crossref
Crossref
Terhi Kurko, Leena K. Saastamoinen, Annamari Tuulio-Henriksson, Tero Taiminen, Jari Tiihonen, Marja Airaksinen & Jarmo Hietala. (2018) Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiology and Drug Safety 27:6, pages 674-682.
Crossref
Crossref
Shirley Musich, Shaohung S. Wang, Luke B. Slindee, Lynn Saphire & Ellen Wicker. (2018) Characteristics of New-Onset and Chronic Sleep Medication Users Among Older Adults: A Retrospective Study of a US Medigap Plan Population using Propensity Score Matching. Drugs & Aging 35:5, pages 467-476.
Crossref
Crossref
Víviam Vargas Barros, Emérita Sátiro Opaleye, Marcelo Demarzo, Sarah Bowen, Daniela Fernández Curado, Helena Hachul & Ana Regina Noto. (2018) Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: A cross-sectional study. PLOS ONE 13:3, pages e0194035.
Crossref
Crossref
Nir Treves, Amichai Perlman, Lital Kolenberg Geron, Angham Asaly & Ilan Matok. (2018) Z-drugs and risk for falls and fractures in older adults—a systematic review and meta-analysis. Age and Ageing 47:2, pages 201-208.
Crossref
Crossref
María del Mar Castillo Guerrero. (2018) Poisonings and deaths caused by benzodiazepine drugs in costa rica, from 2007 to 2014. MOJ Toxicology 4:1.
Crossref
Crossref
A. H. C. Santana & Castro Neto A. G.. (2018) Avaliação das Apreensões de Benzodiazepínicos na Cidade de Recife – PE, Brasil. Brazilian Journal of Forensic Sciences, Medical Law and Bioethics 7:4, pages 252-264.
Crossref
Crossref
Tien-Yu Chen, John W. Winkelman, Wei-Chung Mao, Chia-Lin Liu, Chung-Yao Hsu & Chi-Shin Wu. (2018) The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia. Chest 153:1, pages 161-171.
Crossref
Crossref
Andrea Bielli, Pilar Bacci, Gabriela Bruno, Nancy Calisto & Santiago Navarro. (2017) La controversia científico-técnica sobre las benzodiacepinas en profesionales de la salud pública de Uruguay. Physis: Revista de Saúde Coletiva 27:4, pages 933-958.
Crossref
Crossref
Soo-Hee Hwang, Seungjin Han, Hyojung Choi, Choonseon Park, Sun Min Kim & Tae Hyun Kim. (2017) Trends in the prescription of benzodiazepines for the elderly in Korea. BMC Psychiatry 17:1.
Crossref
Crossref
Pierre Verger, Sébastien Cortaredona, Hélène Jacqmin-Gadda, Marie Tournier & Hélène Verdoux. (2017) Eight-Year Follow-up of Hypnotic Delivery by Adults Aged 50 and Older from an Insurance Database. Sleep 40:11.
Crossref
Crossref
Gaigai Wang, Chao Liu, Binbin Li, Yingchun Wang, Kristof Van Hecke, Erik V. Van der Eycken, Olga P. Pereshivko & Vsevolod A. Peshkov. (2017) Diversity-oriented synthesis of 1,3-benzodiazepines. Tetrahedron 73:44, pages 6372-6380.
Crossref
Crossref
Jagriti Narang, Nitesh Malhotra, Chaitali Singhal, Ashish Mathur, Anoop Krishna PN & C.S. Pundir. (2017) Detection of alprazolam with a lab on paper economical device integrated with urchin like Ag@ Pd shell nano-hybrids. Materials Science and Engineering: C 80, pages 728-735.
Crossref
Crossref
Karoliina Karjalainen, Tomi Lintonen & Pekka Hakkarainen. (2017) Illicit drug use is increasing among non-medical users of prescription drugs—Results from population-based surveys 2002–2014. Drug and Alcohol Dependence 178, pages 430-434.
Crossref
Crossref
Emily Reeve, Magdalene Ong, Angela Wu, Jesse Jansen, Mirko Petrovic & Danijela Gnjidic. (2017) A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European Journal of Clinical Pharmacology 73:8, pages 927-935.
Crossref
Crossref
Steven G. Morgan & Deirdre Weymann. (2017) Patterns, predictors and persistence of chronic sedative use: a population-based observational study of older adults in British Columbia, Canada. European Journal of Clinical Pharmacology 73:8, pages 1001-1008.
Crossref
Crossref
Louis Jacob, Michael A. Rapp & Karel Kostev. (2017) Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Therapeutic Advances in Psychopharmacology 7:6-7, pages 191-200.
Crossref
Crossref
Brandi P. Cotton, Matthew C. Lohman, Jessica M. Brooks, Karen L. Whiteman, Yuhua Bao, Rebecca L. Greenberg & Martha L. Bruce. (2017) Prevalence of and Factors Related to Prescription Opioids, Benzodiazepines, and Hypnotics Among Medicare Home Health Recipients. Home Healthcare Now 35:6, pages 304-313.
Crossref
Crossref
Elin Kristin Bye & Ingeborg Rossow. (2017) Concomitant alcohol and sedative-hypnotic drug use among the elderly in Norway. Nordic Studies on Alcohol and Drugs 34:1, pages 18-27.
Crossref
Crossref
Deirdre Weymann, Emilie J. Gladstone, Kate Smolina & Steven G. Morgan. (2017) Long-term sedative use among community-dwelling adults: a population-based analysis. CMAJ Open 5:1, pages E52-E60.
Crossref
Crossref
Xiaoguang Li, Zhihao Wang, Lu Tan, Yali Wang, Chengbiao Lu, Rongxiang Chen, Shujuan Zhang, Yuan Gao, Yanchao Liu, Yaling Yin, Xinghua Liu, Enjie Liu, Ying Yang, Yu Hu, Zhipeng Xu, Fuqiang Xu, Jie Wang, Gong-Ping Liu & Jian-Zhi Wang. (2017) Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice. Molecular Therapy 25:1, pages 140-152.
Crossref
Crossref
Giancarlo Lucchetti & Alessandra L.G. Lucchetti. (2017) Inappropriate prescribing in older persons: A systematic review of medications available in different criteria. Archives of Gerontology and Geriatrics 68, pages 55-61.
Crossref
Crossref
David J. Kim & Srdjan S. Nedeljkovic. 2017. Pain Medicine. Pain Medicine
173
174
.
Vahid Nikoui, Sattar Ostadhadi, Pardis Azhand, Samira Zolfaghari, Shayan Amiri, Mehrdad Foroohandeh, Manijeh Motevalian, Ali Mohammad Sharifi & Azam Bakhtiarian. (2016) The effect of nitrazepam on depression and curiosity in behavioral tests in mice: The role of potassium channels. European Journal of Pharmacology 791, pages 369-376.
Crossref
Crossref
David Franklin Niedrig, Liesa Hoppe, Sarah Mächler, Heike Russmann & Stefan Russmann. (2016) Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events. PLOS ONE 11:10, pages e0163224.
Crossref
Crossref
F. Cosci, G. Mansueto, M. Faccini, R. Casari & F. Lugoboni. (2016) Socio-demographic and clinical characteristics of benzodiazepine long-term users: Results from a tertiary care center. Comprehensive Psychiatry 69, pages 211-215.
Crossref
Crossref
Mohammed Abed Al-Hussein Salman & Nabeel Abed Abdul-Rida. (2016) Synthesis of new derivatives of aryl-clonazepam via Suzuki Cross-coupling reaction. European Journal of Chemistry 7:2, pages 152-155.
Crossref
Crossref
Chris F Johnson, Cornelia Frei, Noreen Downes, Stuart A McTaggart & Gazala Akram. (2016) Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. British Journal of General Practice 66:647, pages e410-e415.
Crossref
Crossref
Ajay K Parsaik, Soniya S Mascarenhas, Darrow Khosh-Chashm, Aqeel Hashmi, Vineeth John, Olaoluwa Okusaga & Balwinder Singh. (2015) Mortality associated with anxiolytic and hypnotic drugs—A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry 50:6, pages 520-533.
Crossref
Crossref
Jeremy Gauntlett-Gilbert, Dimitri Gavriloff & Peter Brook. (2016) Benzodiazepines May Be Worse Than Opioids. The Clinical Journal of Pain 32:4, pages 285-291.
Crossref
Crossref
Kevin C. Honeychurch, Joshua Brooks & John P. Hart. (2016) Development of a voltammetric assay, using screen-printed electrodes, for clonazepam and its application to beverage and serum samples. Talanta 147, pages 510-515.
Crossref
Crossref
M. Mofizul Islam, Suzanne Nielsen, Ian S. McRae, Paul S. Haber, Apo Demirkol, Bridin Murnion, Hester Wilson & Katherine M. Conigrave. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
283
292
.
Antoine Pariente, Sophie Billioti de Gage, Nicholas Moore & Bernard Bégaud. (2015) The Benzodiazepine–Dementia Disorders Link: Current State of Knowledge. CNS Drugs 30:1, pages 1-7.
Crossref
Crossref
Malcolm Lader & Andri Kyriacou. (2016) Withdrawing Benzodiazepines in Patients With Anxiety Disorders. Current Psychiatry Reports 18:1.
Crossref
Crossref
Ingeborg Rossow & Jørgen G Bramness. (2015) The total sale of prescription drugs with an abuse potential predicts the number of excessive users: a national prescription database study. BMC Public Health 15:1.
Crossref
Crossref
T.A.T. Kurko, L.K. Saastamoinen, S. Tähkäpää, A. Tuulio-Henriksson, T. Taiminen, J. Tiihonen, M.S. Airaksinen & J. Hietala. (2015) Long-term use of benzodiazepines: Definitions, prevalence and usage patterns – a systematic review of register-based studies. European Psychiatry 30:8, pages 1037-1047.
Crossref
Crossref
K. O'Sullivan, U. Reulbach, F. Boland, N. Motterlini, D. Kelly, K. Bennett & T. Fahey. (2015) Benzodiazepine prescribing in children under 15 years of age receiving free medical care on the General Medical Services scheme in Ireland. BMJ Open 5:6, pages e007070-e007070.
Crossref
Crossref
Andy Maun, Catrin Wessman, Pär-Daniel Sundvall, Jörgen Thorn & Cecilia Björkelund. (2015) Is the quality of primary healthcare services influenced by the healthcare centre’s type of ownership?—An observational study of patient perceived quality, prescription rates and follow-up routines in privately and publicly owned primary care centres. BMC Health Services Research 15:1.
Crossref
Crossref
Annie Umbricht & Martha L. Velez. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
343
365
.
Liz Brodie, Jayne Donaldson & Susan Watt. (2014) Non-medical prescribers and benzodiazepines: A qualitative study. Nurse Prescribing 12:7, pages 353-359.
Crossref
Crossref
Malcolm Lader. (2014) Benzodiazepine harm: how can it be reduced?. British Journal of Clinical Pharmacology 77:2, pages 295-301.
Crossref
Crossref
Coral Sirdifield, Sibyl Anthierens, Hanne Creupelandt, Susan Y Chipchase, Thierry Christiaens & Aloysius Niroshan Siriwardena. (2013) General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Family Practice 14:1.
Crossref
Crossref
Helen Gallagher. (2013) Addressing the Issue of Chronic, Inappropriate Benzodiazepine Use: How Can Pharmacists Play a Role?. Pharmacy 1:2, pages 65-93.
Crossref
Crossref
B. Dell’osso & M. Lader. (2013) Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal. European Psychiatry 28:1, pages 7-20.
Crossref
Crossref
Malcolm Lader. (2011) Benzodiazepines revisited—will we ever learn?. Addiction 106:12, pages 2086-2109.
Crossref
Crossref
Leonie Manthey, Erik J. Giltay, Tineke van Veen, Arie Knuistingh Neven, Frans G. Zitman & Brenda W.J.H. Penninx. (2011) Determinants of Initiated and Continued Benzodiazepine Use in the Netherlands Study of Depression and Anxiety. Journal of Clinical Psychopharmacology 31:6, pages 774-779.
Crossref
Crossref
Michel Préville, Helen-Maria Vasiliadis, Cindy Bossé, Pierre-Alexandre Dionne, Philippe Voyer & Joëlle Brassard. (2011) Pattern of Psychotropic Drug Use among Older Adults Having a Depression or an Anxiety Disorder: Results from the Longitudinal ESA Study. The Canadian Journal of Psychiatry 56:6, pages 348-357.
Crossref
Crossref